Guardian Pharmacy Services, Inc.
For the period ended Mar 31, 2025. Filed May 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 12, 2025
GRDN$49.85+6.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| Three Months Ended March 31, | ||
|---|---|---|
| (In thousands) | 2024 | 2025 |
| Operating activities | ||
| Net income | $7,095 | $9,273 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 4,751 | 5,267 |
| Share-based compensation expense | 5,945 | 3,968 |
| Provision for losses on accounts receivable | 1,395 | 896 |
| Other | (26) | (141) |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (9,542) | (1,007) |
| Inventories | (1,831) | (2,881) |
| Other current assets | (2,211) | (1,588) |
| Accounts payable | 7,187 | 1,874 |
| Accrued compensation | (7,309) | (3,953) |
| Other operating liabilities | 3,200 | 5,842 |
| Net cash provided by operating activities | 8,654 | 17,550 |
| Investing activities | ||
| Purchases of property and equipment | (3,692) | (5,805) |
| Other | 94 | 260 |
| Net cash used in investing activities | (3,598) | (5,545) |
| Financing activities | ||
| Payments of equity offering costs | — | (1,534) |
| Repayment of notes payable | (1,000) | — |
| Borrowings from line of credit | 57,800 | — |
| Repayments of line of credit | (50,800) | — |
| Principal payments on finance lease obligations | (1,103) | (1,132) |
| Contributions from non-controlling interests | 278 | 135 |
| Distributions to non-controlling interests | (3,679) | (135) |
| Member distributions | (7,130) | — |
| Net cash used in financing activities | (5,634) | (2,666) |
| Net change in cash and cash equivalents | (578) | 9,339 |
| Cash and cash equivalents, beginning of period | 752 | 4,660 |
| Cash and cash equivalents, end of period | $174 | $13,999 |
| Supplemental disclosure of cash flow information | ||
| Cash paid during the year for interest | $757 | $175 |
| Supplemental disclosure of non-cash investing and financing activities | ||
| Purchases of property and equipment through finance leases | $610 | $1,591 |
Guardian Pharmacy Services, Inc. and Subsidiaries
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.